Title : Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models.

Pub. Date : 2021 Nov

PMID : 34478849






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, due to its cross-reactivity to RGMc/hemojuvelin, ABT-207 causes iron accumulation in vivo, which could present a safety liability. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid hemojuvelin BMP co-receptor Mus musculus
2 However, due to its cross-reactivity to RGMc/hemojuvelin, ABT-207 causes iron accumulation in vivo, which could present a safety liability. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid hemojuvelin BMP co-receptor Mus musculus
3 Elezanumab, a human monoclonal antibody generated by in vitro PROfusion mRNA display technology, competes with ABT-207 in binding to N-RGMa but lacks RGMc cross-reactivity with no impact on iron metabolism. 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid repulsive guidance molecule family member A Mus musculus